US 10532050
Formulations of oxabicycloheptanes and oxabicycloheptenes
granted A61KA61K31/197A61K31/34
Quick answer
US patent 10532050 (Formulations of oxabicycloheptanes and oxabicycloheptenes) held by Lixte Biotechnology, Inc. expires Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Lixte Biotechnology, Inc.
- Grant date
- Tue Jan 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/197, A61K31/34, A61K31/4525, A61K31/496